Tag: Johnson & Johnson
-
Pneumonia Trial Of Janssen / J&J Antibiotic Doribax Was Stopped In May 2011 — We Learn From The FDA In January 2012
"Significant Safety Concern": Higher Death Rate For Doribax In Ventilator-Associated Pneumonia When Compared To Patients Receiving Imipenem Therapy (Posted by Tom Lamb at DrugInjuryWatch.com) ______________________________________________________________________________ UPDATE: "Doribax (doripenem for injection) – Higher Mortality Rate and…
-
Ortho Evra Update: October 2011 FDA Study Finds Increased Risk Of Blood Clot Side Effects Deep Vein Thrombosis & Pulmonary Embolism
Given These New FDA Drug Safety Findings About Ortho Evra, What Will Two Advisory Committees Do At Joint Meeting On December 9, 2011? (Posted by Tom Lamb at DrugInjuryWatch.com) On October 27, 2011 the FDA…
-
First Levaquin Lawsuit Trial In Federal Court MDL Litigation Started In Mid-November 2010
John Schedin v. Johnson and Johnson: Man Ruptured Achilles Tendons In Both Feet After Taking Levaquin (Posted by Tom Lamb at DrugInjuryWatch.com) _____________________________________________________________________________ UPDATES: "J&J Loses First Trial on Warnings of Levaquin Risk" (12/8/10,…
-
Recent Report About Ortho Evra Safety Seems To Contradict Earlier Findings From Same Group
Third Boston Collaborative Drug Surveillance Program Study Analysis Concerning Ortho Evra And Blood Clot Side Effect Risk Causes Confusion (Posted by Tom Lamb at DrugInjuryWatch.com)Let us start with this relatively recent medical journal article, "Postmarketing study of…